Soligenix
SNGX
#10250
Rank
ยฃ10.42 M
Marketcap
ยฃ1.03
Share price
1.46%
Change (1 day)
-59.71%
Change (1 year)

P/S ratio for Soligenix (SNGX)

P/S ratio as of January 2026 (TTM): N/A

According to Soligenix's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.82. At the end of 2025 the company had a P/S ratio of N/A.

P/S ratio history for Soligenix from 2001 to 2025

PS ratio at the end of each year

Year P/S ratio Change
2025N/A-100%
202462.0102.81%
202330.6-60.9%
202278.2-90.79%
20218494189.27%
202019.8101.75%
20199.81155.78%
20183.83-14.46%
20174.48282.97%
20161.17-70.95%
20154.0321.05%
20143.33-69.62%
201311.0414.17%
20122.13166.77%
20110.7988-96.21%
201021.127.96%
200916.5523.38%
20082.64-79.35%
200712.879.41%
20067.1455.4%
20054.59-82.98%
200427.0
2001> 1000

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Cleveland BioLabs
CBLI
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.8805N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
2.43N/A๐Ÿ‡ซ๐Ÿ‡ท France
Pfizer
PFE
2.29N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
5.48N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
10.4N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
92.5N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
2.24N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel